Single-daily-dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle

Details for Australian Patent Application No. 2002339078 (hide)

Owner FLAMEL TECHNOLOGIES

Inventors Castan, Catherine; Meyrueix, Remi; Soula, Gerard

Agent Davies Collison Cave

Pub. Number AU-A-2002339078

PCT Number PCT/FR02/01745

PCT Pub. Number WO2002/094285

Priority 01/06854 23.05.01 FR

Filing date 23 May 2002

Wipo publication date 3 December 2002

International Classifications

A61K 031/64 - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide

A61K 009/50 Medicinal preparations characterised by special physical form - Microcapsules

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 01/06854 23.05.01 FR

8 May 2003 Application Open to Public Inspection

  Published as AU-A-2002339078

22 December 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002339079-Exercise device to prevent DVT

2002339077-ENZYMES AND ENZYME INHIBITION